Related references
Note: Only part of the references are listed.T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy
Tori N. Yamamoto et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Peng Jiang et al.
NATURE MEDICINE (2018)
Ovarian cancer stem cells promote tumour immune privilege and invasion via CCL5 and regulatory T cells
Y. You et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2018)
An anti-CD3/anti-CLL-1 bispecific antibody for the treatment of acute myeloid leukemia
Steven R. Leong et al.
BLOOD (2017)
The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2017)
Impressive and durable response to nivolumab in a patient with metastatic type 2 papillary renal cell carcinoma: On-label but without evidence
Diego A. Adrianzen Herrera et al.
INVESTIGATIONAL NEW DRUGS (2017)
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
Darshan S. Chandrashekar et al.
NEOPLASIA (2017)
Treatment of renal cell carcinoma: Current status and future directions
Pedro C. Barata et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells
Taiwen Li et al.
CANCER RESEARCH (2017)
Identifying network-based biomarkers of complex diseases from high-throughput data
Zhi-Ping Liu
BIOMARKERS IN MEDICINE (2016)
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma
W. Marston Linehan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
R. L. Ferris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Papillary renal cell carcinoma: A review of the current therapeutic landscape
Giulia Courthod et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2015)
EAU Guidelines on Renal Cell Carcinoma: 2014 Update
Borje Ljungberg et al.
EUROPEAN UROLOGY (2015)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
H. Borghaei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
Stephen M. Ansell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
R. J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Tissue-based map of the human proteome
Mathias Uhlen et al.
SCIENCE (2015)
cytoHubba: identifying hub objects and sub-networks from complex interactome
Chia-Hao Chin et al.
BMC SYSTEMS BIOLOGY (2014)
The Inflammatory Chemokine CCL5 and Cancer Progression
Donatella Aldinucci et al.
MEDIATORS OF INFLAMMATION (2014)
Inflammation-Induced Hepatocellular Carcinoma Is Dependent on CCR5 in Mice
Neta Barashi et al.
HEPATOLOGY (2013)
Macrophage-secreted cytokines drive pancreatic acinar-to-ductal metaplasia through NF-κB and MMPs
Geou-Yarh Liou et al.
JOURNAL OF CELL BIOLOGY (2013)
The Transcription Factors T-bet and Eomes Control Key Checkpoints of Natural Killer Cell Maturation
Scott M. Gordon et al.
IMMUNITY (2012)
Comparing Statistical Methods for Constructing Large Scale Gene Networks
Jeffrey D. Allen et al.
PLOS ONE (2012)
Natural Innate and Adaptive Immunity to Cancer
Matthew D. Vesely et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
VennDiagram: a package for the generation of highly-customizable Venn and Euler diagrams in R
Hanbo Chen et al.
BMC BIOINFORMATICS (2011)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
Granzymes in cancer and immunity
S. P. Cullen et al.
CELL DEATH AND DIFFERENTIATION (2010)
Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients
Julien Fourcade et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
WGCNA: an R package for weighted correlation network analysis
Peter Langfelder et al.
BMC BIOINFORMATICS (2008)
Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways
Brian T. Fife et al.
IMMUNOLOGICAL REVIEWS (2008)
Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R
Peter Langfelder et al.
BIOINFORMATICS (2008)
Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses
Manish J. Butte et al.
IMMUNITY (2007)
Recent progress in the management of advanced renal cell carcinoma
Jorge A. Garcia et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2007)
Immunostimulatory monoclonal antibodies for cancer therapy
Ignacio Melero et al.
NATURE REVIEWS CANCER (2007)
Immune responses to p53 in patients with cancer:enrichment in tetramer+p53 peptide-specific T cells and regulatory T cells at tumor sites
AE Albers et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
The role of fas ligand and transforming growth factor β in tumor progression -: Molecular mechanisms of immune privilege via Fas-mediated apoptosis and potential targets for cancer therapy
R Kim et al.
CANCER (2004)
Control of effector CD8+ T cell function by the transcription factor Eomesodermin
EL Pearce et al.
SCIENCE (2003)
Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles
G Andreola et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Share Paper
